Dannielle D. Engle, Ph.D.

2011 Biology University of California, San Diego, La Jolla, CA 
Oncology, Human Development, Cell Biology
"Dannielle Engle"


Sign in to add mentor
Geoffrey M. Wahl grad student 2011 UCSD
 (Links between development and cancer: Fetal mammary stem cells and human breast cancer.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liang G, Oh TG, Hah N, et al. (2023) Inhibiting stromal Class I HDACs curbs pancreatic cancer progression. Nature Communications. 14: 7791
Liang G, Oh TG, Hah N, et al. (2023) Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression. Biorxiv : the Preprint Server For Biology
Gulay KCM, Zhang X, Pantazopoulou V, et al. (2023) Dual inhibition of KRASG12D and pan-ERBB is synergistic in pancreatic ductal adenocarcinoma. Cancer Research
Lumibao JC, Tremblay JR, Hsu J, et al. (2022) Altered glycosylation in pancreatic cancer and beyond. The Journal of Experimental Medicine. 219
Dasgupta A, Shukla SK, Vernucci E, et al. (2020) SIRT1-NOX4 signaling axis regulates cancer cachexia. The Journal of Experimental Medicine. 217
Ponz-Sarvise M, Corbo V, Tiriac H, et al. (2019) Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Engle DD, Tiriac H, Rivera KD, et al. (2019) The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice. Science (New York, N.Y.). 364: 1156-1162
Elyada E, Bolisetty M, Laise P, et al. (2019) Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts. Cancer Discovery
Engle D, Tiriac H, Rivera K, et al. (2019) Abstract PR12: The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice Cancer Research. 79
Tiriac H, Belleau P, Engle D, et al. (2019) Abstract C57: Organoid profiling identifies common responders to chemotherapy in pancreatic cancer Cancer Research. 79
See more...